Impact of 111In-CYT-103 on the surgical management of patients with ovarian cancer.
Surwit
E A
EA
University of Arizona, Tucson.
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000911:Antibodies, Monoclonal; D005260:Female; D006801:Humans; D007205:Indium Radioisotopes; D008875:Middle Aged; D009367:Neoplasm Staging; D009842:Oligopeptides; D010051:Ovarian Neoplasms / Q000000981:diagnostic imaging* / Q000473:pathology / Q000601:surgery*; D004369:Pentetic Acid / Q000031:analogs & derivatives*; D016719:Radioimmunodetection
D000911:Antibodies, Monoclonal; C063430:Indium 111In-satumomab pendetide; D007205:Indium Radioisotopes; D009842:Oligopeptides; D004369:Pentetic Acid